Posts by Sandra Ansanay-Alex
Adaptyv Raises CHF 6,40 million to Accelerate AI-Driven Protein Validation
Vaud-based startup Adaptyv, specializing in the experimental validation of AI-generated proteins, has raised CHF 6,40 million in seed funding. The round was led by Ace Ventures with participation from ByFounders, Founderful, LongGame, and several individual investors. At the same time, the company announced the public launch of its fully automated cloud laboratory platform, now…
Read MoreA Blood Test Designed to Differentiate Depression and Bipolar Disorder
ALCEDIAG, OM Pharma Suisse, and Unilabs announce the launch of EDIT-B®, the world’s first CE-marked and Swissmedic compliant blood test designed to differentiate depression and bipolar disorder, now available nationwide in clinical routine in Switzerland and Liechtenstein. This innovative diagnostic solution, a breakthrough in mental health diagnostics, will be accessible to clinicians and patients, addressing…
Read MoreCria Technologies secures CHF 40,000 at the second stage of Venture Kick
The Geneva-based and FONGIT incubated startup revolutionizes biopharma cold chain logistics Cria Technologies, is tackling one of the most pressing inefficiencies in the pharmaceutical and biotech cold chain: outdated, bulky, and fragile packaging systems that rely heavily on dry ice. These legacy solutions are increasingly inadequate for transporting emerging personalized therapies that require ultra-low…
Read MoredEEGtal Gets a CHF 640,000 Support From Innosuisse
dEEGtal Insight SA is a pioneering spin-off, of the Geneva University Hospitals (the EEG and Epilepsy Unit) and the University of Geneva, focused on transforming early detection and diagnosis of epilepsy. Innosuisse recently approved a CHF 640,000 support. This forward-thinking initiative leverages advanced AI-powered software to deliver precise and timely insights to neurologists, enabling…
Read MoreLichtsteiner Foundation
Try to be one of the 10 early-stage healthcare startups supported by the Lichtsteiner Foundation each year. Application accepted throughout the year. The purpose of the Lichtsteiner Foundation is to promote innovations in healthcare in order to improve people’s health worldwide. The Lichtsteiner Foundation is a charitable, tax-exempt, independent foundation under Swiss law with…
Read MoreThree Leading Digital Health Hubs Unite to Boost European Innovation
Three major European digital health ecosystems are teaming up to create a pan-European alliance aimed at accelerating the growth and cross-border scaling of digital health solutions. The Future of Health Grant (Switzerland), Future4care (France/Germany), and the Barcelona & Madrid Health Hub (Spain) signed partnership agreements during the Health Revolution Congress 2025 in Barcelona. Their…
Read MoreiOnctura Expands Roginolisib Trials to the US
iOnctura, a Geneva-based clinical-stage precision oncology company focused on neglected and hard-to-treat cancers, announces the expansion of its clinical trial programme for lead candidate roginolisib into the United States. Several US trial sites are now enrolling patients in the OCULE-01 Phase II study in metastatic uveal melanoma, with an additional study, led by Dr…
Read MoreBearmind and Bauer Announce Strategic Partnership
The Vaud-based medtech startup and the Canadian manufacturer of ice hockey equipment want redefine the future of ice hockey helmets through datadriven innovation This partnership combines Bauer’s industry-leading expertise in protective equipment with Bearmind’s advanced sensor and analytics platform to create the next generation of smart hockey helmets – gear that not only protects…
Read MoreAevis Victoria’s Profits Have Almost Tripled in a Decade
The Fribourg-based group of private clinics and luxury hotels (Genolier, Generale-Beaulieu Clinic Geneva, etc.) recorded profits of CHF 12.2 million after six months in 2016, up from CHF 4.5 million. Aevis Victoria posted a positive result in the first half of the year, with profits up almost threefold.Net sales also rose by 15.3% year-on-year…
Read MoreEarlySight Secures CHF 6.1 Million to Advance Vision-Saving Technology
EarlySight, a Geneva-based startup, is excited to announce the successful extension of its Seed round to CHF 6.1 million, with Zürcher Kantonalbank joining its strong syndicate of investors, which includes Verve Ventures, Nina Capital, NovaCapital, and CADFEM International GmbH. This new funding marks a significant milestone in its mission to transform retinal diagnostics. It…
Read More